TARDBP and amyotrophic lateral sclerosis: Although future studies using animal models are required to clarify whether Abe suppresses TDP-43 accumulation by promoting autophagic flux, the present results indicate that Abe is a suitable candidate for the treatment of ALS and FTLD-TDP through its acceleration of autophagic flux.